脑电图生物反馈作为物质使用障碍的一种治疗方法：综述、疗效评级及进一步研究建议
EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research.
作者信息
Sokhadze Tato M, Cannon Rex L, Trudeau David L
机构信息
Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA.
出版信息
Appl Psychophysiol Biofeedback. 2008 Mar;33(1):1-28. doi: 10.1007/s10484-007-9047-5. Epub 2008 Jan 24.
Abstract
Electroencephalographic (EEG) biofeedback has been employed in substance use disorder (SUD) over the last three decades. The SUD is a complex series of disorders with frequent comorbidities and EEG abnormalities of several types. EEG biofeedback has been employed in conjunction with other therapies and may be useful in enhancing certain outcomes of therapy. Based on published clinical studies and employing efficacy criteria adapted by the Association for Applied Psychophysiology and Biofeedback and the International Society for Neurofeedback and Research, alpha theta training-either alone for alcoholism or in combination with beta training for stimulant and mixed substance abuse and combined with residential treatment programs, is probably efficacious. Considerations of further research design taking these factors into account are discussed and descriptions of contemporary research are given.
摘要
在过去三十年中，脑电图（EEG）生物反馈已被应用于物质使用障碍（SUD）。SUD是一系列复杂的疾病，常伴有多种合并症和几种类型的脑电图异常。EEG生物反馈已与其他疗法联合使用，可能有助于提高某些治疗效果。根据已发表的临床研究，并采用应用心理生理学和生物反馈协会以及国际神经反馈和研究协会调整的疗效标准，α-θ训练——单独用于治疗酒精中毒，或与β训练联合用于治疗兴奋剂和混合物质滥用，并与住院治疗项目相结合，可能是有效的。本文讨论了在考虑这些因素的情况下进一步研究设计的注意事项，并给出了当代研究的描述。
相似文献
1
EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research.
Appl Psychophysiol Biofeedback. 2008 Mar;33(1):1-28. doi: 10.1007/s10484-007-9047-5. Epub 2008 Jan 24.
2
Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder.
Appl Psychophysiol Biofeedback. 2005 Jun;30(2):95-114. doi: 10.1007/s10484-005-4305-x.
3
Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation.
Child Adolesc Psychiatr Clin N Am. 2005 Jan;14(1):55-82, vi. doi: 10.1016/j.chc.2004.07.004.
4
The treatment of addictive disorders by brain wave biofeedback: a review and suggestions for future research.
Clin Electroencephalogr. 2000 Jan;31(1):13-22. doi: 10.1177/155005940003100107.
5
Treatment of attention deficit hyperactivity disorder with neurotherapy.
Clin Electroencephalogr. 2000 Jan;31(1):30-7. doi: 10.1177/155005940003100109.
6
The state of EEG biofeedback therapy (EEG operant conditioning) in 2000: an editor's opinion.
Clin Electroencephalogr. 2000 Jan;31(1):V-VII.
7
[The use of individual EEG peculiarities for increase of neurofeedback efficiency].
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(2):31-6.
8
EEG biofeedback in the treatment of attention deficit hyperactivity disorder.
Altern Med Rev. 2007 Jun;12(2):146-51.
9
Correlates of alpha, beta and theta wave production.
J Clin Psychol. 1979 Apr;35(2):364-9.
10
The Current Evidence Levels for Biofeedback and Neurofeedback Interventions in Treating Depression: A Narrative Review.
Neural Plast. 2021 Feb 4;2021:8878857. doi: 10.1155/2021/8878857. eCollection 2021.
引用本文的文献
1
Effect of Neurofeedback Training and Swimming Exercise on the Electroencephalographic Changes and Craving in Methamphetamine-dependent Patients.
Basic Clin Neurosci. 2025;16(Spec Issue):179-192. doi: 10.32598/bcn.2023.886.4. Epub 2025 Mar 18.
2
Analyze the Potential Benefits of Nature-Based Filming for Young People.
Appl Psychophysiol Biofeedback. 2025 May 22. doi: 10.1007/s10484-025-09717-x.
3
Cost, research, and education: Providers' perspectives on making neurofeedback more accessible.
Res Sq. 2025 May 7:rs.3.rs-6414373. doi: 10.21203/rs.3.rs-6414373/v1.
4
Predicting vasovagal reactions to needles from video data using 2D-CNN with GRU and LSTM.
PLoS One. 2025 Jan 24;20(1):e0314038. doi: 10.1371/journal.pone.0314038. eCollection 2025.
5
Brain regulation training improves emotional competences in patients with alcohol use disorder.
Soc Cogn Affect Neurosci. 2024 Aug 1;19(1). doi: 10.1093/scan/nsae048.
6
Neurofeedback and meditation technology in outpatient offender treatment: a feasibility and usability pilot study.
Front Psychol. 2024 Jun 4;15:1354997. doi: 10.3389/fpsyg.2024.1354997. eCollection 2024.
7
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.
INNOSC Theranostics Pharmacol Sci. 2024 Apr 30;7(2):1472. doi: 10.36922/itps.1472.
8
Integrated use of biofeedback and neurofeedback techniques in treating pathological conditions and improving performance: a narrative review.
Front Neurosci. 2024 Mar 19;18:1358481. doi: 10.3389/fnins.2024.1358481. eCollection 2024.
9
Neurophysiological hallmarks of Huntington's disease progression: an EEG and fMRI connectivity study.
Front Aging Neurosci. 2023 Dec 15;15:1270226. doi: 10.3389/fnagi.2023.1270226. eCollection 2023.
10
Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging.
Subst Abuse Rehabil. 2023 Aug 10;14:99-111. doi: 10.2147/SAR.S362861. eCollection 2023.
本文引用的文献
1
Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
Med Hypotheses. 2007;69(5):1054-60. doi: 10.1016/j.mehy.2006.12.062. Epub 2007 Apr 30.
2
The effects of neurofeedback training in the cognitive division of the anterior cingulate gyrus.
Int J Neurosci. 2007 Mar;117(3):337-57. doi: 10.1080/00207450500514003.
3
Preliminary feasibility and efficacy of a brief motivational intervention with psychophysiological feedback for cocaine abuse.
Subst Abus. 2006 Dec;27(4):9-20. doi: 10.1300/j465v27n04_02.
4
Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
Neurosci Lett. 2006 Dec 13;410(1):1-5. doi: 10.1016/j.neulet.2006.05.005. Epub 2006 Oct 31.
5
Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
Med Hypotheses. 2007;68(4):844-52. doi: 10.1016/j.mehy.2006.08.041. Epub 2006 Oct 27.
6
Reorganization of the composition of brain oscillations and their temporal characteristics in opioid dependent patients.
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1453-65. doi: 10.1016/j.pnpbp.2006.06.005. Epub 2006 Aug 4.
7
Increased local and decreased remote functional connectivity at EEG alpha and beta frequency bands in opioid-dependent patients.
Psychopharmacology (Berl). 2006 Sep;188(1):42-52. doi: 10.1007/s00213-006-0474-4. Epub 2006 Jul 19.
8
The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption.
Brain Res Rev. 2006 Sep;52(2):368-80. doi: 10.1016/j.brainresrev.2006.04.007.
9
Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition.
J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):208-16. doi: 10.1176/jnp.2006.18.2.208.
10
Cannabinoids and prefrontal cortical function: insights from preclinical studies.
Neurosci Biobehav Rev. 2006;30(5):680-95. doi: 10.1016/j.neubiorev.2005.12.002. Epub 2006 Mar 29.
Zotero 插件